300 related articles for article (PubMed ID: 33672324)
41. Hispidulin Enhances Temozolomide (TMZ)-Induced Cytotoxicity against Malignant Glioma Cells
Chen Z; Zhu G; Sheng C; Lei J; Song S; Zhu J
Comput Intell Neurosci; 2022; 2022():5266770. PubMed ID: 35800695
[TBL] [Abstract][Full Text] [Related]
42. Chaperone-mediated autophagy and disease: Implications for cancer and neurodegeneration.
Gómez-Sintes R; Arias E
Mol Aspects Med; 2021 Dec; 82():101025. PubMed ID: 34629183
[TBL] [Abstract][Full Text] [Related]
43. Hsa_circ_0110757 upregulates ITGA1 to facilitate temozolomide resistance in glioma by suppressing hsa-miR-1298-5p.
Li H; Liu Q; Chen Z; Wu M; Zhang C; Su J; Li Y; Zhang C
Cell Death Dis; 2021 Mar; 12(3):252. PubMed ID: 33674567
[TBL] [Abstract][Full Text] [Related]
44. MSC-AS1 knockdown inhibits cell growth and temozolomide resistance by regulating miR-373-3p/CPEB4 axis in glioma through PI3K/Akt pathway.
Li C; Feng S; Chen L
Mol Cell Biochem; 2021 Feb; 476(2):699-713. PubMed ID: 33106913
[TBL] [Abstract][Full Text] [Related]
45. DYNC1LI2 regulates localization of the chaperone-mediated autophagy receptor LAMP2A and improves cellular homeostasis in cystinosis.
Rahman F; Johnson JL; Zhang J; He J; Pestonjamasp K; Cherqui S; Catz SD
Autophagy; 2022 May; 18(5):1108-1126. PubMed ID: 34643468
[TBL] [Abstract][Full Text] [Related]
46. β-catenin contributes to cordycepin-induced MGMT inhibition and reduction of temozolomide resistance in glioma cells by increasing intracellular reactive oxygen species.
Bi Y; Li H; Yi D; Bai Y; Zhong S; Liu Q; Chen Y; Zhao G
Cancer Lett; 2018 Oct; 435():66-79. PubMed ID: 30081068
[TBL] [Abstract][Full Text] [Related]
47. Chaperone-mediated autophagy controls the turnover of E3 ubiquitin ligase MARCHF5 and regulates mitochondrial dynamics.
Nie T; Tao K; Zhu L; Huang L; Hu S; Yang R; Xu P; Mao Z; Yang Q
Autophagy; 2021 Oct; 17(10):2923-2938. PubMed ID: 33970775
[TBL] [Abstract][Full Text] [Related]
48. Warburg effect-promoted exosomal circ_0072083 releasing up-regulates NANGO expression through multiple pathways and enhances temozolomide resistance in glioma.
Ding C; Yi X; Chen X; Wu Z; You H; Chen X; Zhang G; Sun Y; Bu X; Wu X; Lin Z; Gu J; Lin Y; Kang D
J Exp Clin Cancer Res; 2021 May; 40(1):164. PubMed ID: 33975615
[TBL] [Abstract][Full Text] [Related]
49. Chaperone-Mediated Autophagy after Spinal Cord Injury.
Handa K; Kanno H; Matsuda M; Sugaya T; Murakami T; Prudnikova M; Ozawa H; Itoi E
J Neurotrauma; 2020 Aug; 37(15):1687-1695. PubMed ID: 32233738
[TBL] [Abstract][Full Text] [Related]
50. Knockdown of circHIPK3 Facilitates Temozolomide Sensitivity in Glioma by Regulating Cellular Behaviors Through miR-524-5p/KIF2A-Mediated PI3K/AKT Pathway.
Yin H; Cui X
Cancer Biother Radiopharm; 2021 Sep; 36(7):556-567. PubMed ID: 32833501
[No Abstract] [Full Text] [Related]
51. Circ_0005198 enhances temozolomide resistance of glioma cells through miR-198/TRIM14 axis.
Deng Y; Zhu H; Xiao L; Liu C; Meng X
Aging (Albany NY); 2020 Dec; 13(2):2198-2211. PubMed ID: 33316781
[TBL] [Abstract][Full Text] [Related]
52. Histodenz Separation of Lysosomal Subpopulations for Analysis of Chaperone-mediated Autophagy.
Burns CM; Miller RA; Endicott SJ
Curr Protoc; 2024 Jan; 4(1):e950. PubMed ID: 38197533
[TBL] [Abstract][Full Text] [Related]
53. Chaperone-mediated autophagy: roles in neuroprotection.
Cai Z; Zeng W; Tao K; E Z; Wang B; Yang Q
Neurosci Bull; 2015 Aug; 31(4):452-8. PubMed ID: 26206599
[TBL] [Abstract][Full Text] [Related]
54. Oroxylin A increases the sensitivity of temozolomide on glioma cells by hypoxia-inducible factor 1α/hedgehog pathway under hypoxia.
Wei M; Ma R; Huang S; Liao Y; Ding Y; Li Z; Guo Q; Tan R; Zhang L; Zhao L
J Cell Physiol; 2019 Aug; 234(10):17392-17404. PubMed ID: 30790292
[TBL] [Abstract][Full Text] [Related]
55. STUB1/CHIP is required for HIF1A degradation by chaperone-mediated autophagy.
Ferreira JV; Fôfo H; Bejarano E; Bento CF; Ramalho JS; Girão H; Pereira P
Autophagy; 2013 Sep; 9(9):1349-66. PubMed ID: 23880665
[TBL] [Abstract][Full Text] [Related]
56. Oroxylin A reversed Fibronectin-induced glioma insensitivity to Temozolomide by suppressing IP
Ding Y; Zhou Y; Li Z; Zhang H; Yang Y; Qin H; Xu Q; Zhao L
Life Sci; 2020 Nov; 260():118411. PubMed ID: 32918978
[TBL] [Abstract][Full Text] [Related]
57. Chaperone-mediated autophagy as a therapeutic target for Parkinson disease.
Campbell P; Morris H; Schapira A
Expert Opin Ther Targets; 2018 Oct; 22(10):823-832. PubMed ID: 30185079
[TBL] [Abstract][Full Text] [Related]
58. FOXM1-mediated NUF2 expression confers temozolomide resistance to human glioma cells by regulating autophagy via the PI3K/AKT/mTOR signaling pathway.
Guo L; Wu Z
Neuropathology; 2022 Oct; 42(5):430-446. PubMed ID: 35701983
[TBL] [Abstract][Full Text] [Related]
59. Chaperone-mediated autophagy degrades Keap1 and promotes Nrf2-mediated antioxidative response.
Zhu L; He S; Huang L; Ren D; Nie T; Tao K; Xia L; Lu F; Mao Z; Yang Q
Aging Cell; 2022 Jun; 21(6):e13616. PubMed ID: 35535673
[TBL] [Abstract][Full Text] [Related]
60. The role of chaperone-mediated autophagy in drug resistance.
Teixeira ABDS; Ramalho MCC; Souza I; Andrade IAM; Osawa IYA; Guedes CB; Oliveira BS; Souza Filho CHD; Silva TLD; Moreno NC; Latancia MT; Rocha CRR
Genet Mol Biol; 2024; 47(Suppl 1):e20230317. PubMed ID: 38829285
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
